BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 30514199)

  • 21. Association between the hsa-mir-27a variant and breast cancer risk: a meta-analysis.
    Wang B; Ma N; Wang Y
    Asian Pac J Cancer Prev; 2012; 13(12):6207-10. PubMed ID: 23464432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of two microRNA polymorphisms miR-27 rs895819 and miR-423 rs6505162 with the risk of cancer.
    Zhang H; Zhang Y; Zhao X; Ma X; Yan W; Wang W; Zhao Z; Yang Q; Sun X; Luan H; Gao X; Zhang S
    Oncotarget; 2017 Jul; 8(29):46969-46980. PubMed ID: 28415619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymorphism of ERCC2 Asp312Asn with lung cancer risk: evidence from 20,101 subjects.
    Tan X; Wang Y; Shi L; Xian L; Guo J; Liang G; Chen M
    Genet Test Mol Biomarkers; 2014 Jan; 18(1):50-6. PubMed ID: 24083550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between the interleukin-17A -197G>A (rs2275913) polymorphism and risk of digestive cancer.
    Duan Y; Shi JN; Pan C; Chen HL; Zhang SZ
    Asian Pac J Cancer Prev; 2014; 15(21):9295-300. PubMed ID: 25422215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of a pre-miR-27a polymorphism with cancer risk: an updated meta-analysis.
    Bai RP; Weng Y; Su LL; Jin MJ; Xu ZP; Lu LQ; Chen GD
    Asian Pac J Cancer Prev; 2014; 15(23):10107-14. PubMed ID: 25556434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of miR-146a rs2910164 polymorphism with squamous cell carcinoma risk: a meta-analysis.
    Zhang X; He R; Ren F; Tang R; Chen G
    J BUON; 2015; 20(3):829-41. PubMed ID: 26214637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between miR-124-1 rs531564 polymorphism and risk of cancer: An updated meta-analysis of case-control studies.
    Moazeni-Roodi A; Hashemi M
    EXCLI J; 2018; 17():608-619. PubMed ID: 30108465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between the HSPA1B ±1267A/G polymorphism and cancer risk: a meta-analysis of 14 case-control studies.
    Kuang D; Chen W; Song YZ; Yu YY; Zhang DY; Wu L; Tang J
    Asian Pac J Cancer Prev; 2014; 15(16):6855-61. PubMed ID: 25169537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular endothelial growth factor +405G/C and -2578C/A polymorphisms and breast cancer risk: a meta-analysis.
    Zhang Y; Yu YF; Wang JZ; Jia H
    Genet Mol Res; 2015 Aug; 14(3):8909-18. PubMed ID: 26345822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of CAV1 polymorphisms with the risks of breast cancer: A systematic review and meta-analysis.
    Yan C; Sun C; Ding X; Rizeq FK; Ren M; Yang F; Chen Y; Wang B
    Pathol Res Pract; 2019 Sep; 215(9):152518. PubMed ID: 31303379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between cyclin D1 G870A polymorphism and hepatocellular carcinoma risk: a meta-analysis.
    Luo T; Chen J; Liu JJ; Li H; You XM; Wang HL; Zhu SL; Li LQ
    Onco Targets Ther; 2016; 9():4483-9. PubMed ID: 27499641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Cytotoxic T-lymphocyte Antigen-4 Polymorphisms with Malignant Bone Tumor Risk: A Meta-analysis.
    Zhang C; Hou WH; Ding XX; Wang X; Zhao H; Han XW; Wang WJ
    Asian Pac J Cancer Prev; 2016; 17(8):3785-91. PubMed ID: 27644617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between CASP3 polymorphisms and overall cancer risk: A meta-analysis of case-control studies.
    Hashemi M; Moazeni-Roodi A; Ghavami S
    J Cell Biochem; 2019 May; 120(5):7199-7210. PubMed ID: 30368918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of association between leptin G-2548A polymorphisms and obesity risk: Evidence based on a meta-analysis.
    Yan J; Wang X; Tao H; Yang W; Luo M; Lin F
    Obes Res Clin Pract; 2015; 9(4):389-97. PubMed ID: 25733497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Interleukin-10 -1082A>G (rs1800896) Polymorphism with Predisposition to Breast Cancer: a Meta-Analysis based on 17 Case-Control Studies.
    Abedinzadeh M; Neamatzadeh H; Jafari M; Forat-Yazdi M; Nasiri R; Farahnak S; Foroughi E; Zare-Shehneh M
    Rev Assoc Med Bras (1992); 2018 Aug; 64(8):756-764. PubMed ID: 30673047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between MIR499A rs3746444 polymorphism and breast cancer susceptibility: a meta-analysis.
    Tan SC; Lim PY; Fang J; Mokhtar MFM; Hanif EAM; Jamal R
    Sci Rep; 2020 Feb; 10(1):3508. PubMed ID: 32103099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between miRNA-146a polymorphism and lung cancer susceptibility: A meta-analysis involving 6506 cases and 6576 controls.
    Wang D; Wang Y; Lin Z; Cai L
    Gene; 2020 Oct; 757():144940. PubMed ID: 32640303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pre-miR-27a rs895819A/G polymorphisms in cancer: a meta-analysis.
    Xu Q; He CY; Liu JW; Yuan Y
    PLoS One; 2013; 8(6):e65208. PubMed ID: 23762318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associations of miR-605 rs2043556 polymorphism with the susceptibility and overall survival of lung cancer in Chinese non-smoking females.
    Xu X; Yin Z; Ren Y; Guan P; Zhou B
    Int J Clin Exp Pathol; 2018; 11(1):438-447. PubMed ID: 31938129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of miR-27a polymorphism with the risk of digestive system cancers.
    Yang X; Li X; Hao X; Tian W; Zhou B
    Pathol Res Pract; 2020 Oct; 216(10):153115. PubMed ID: 32853952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.